To assess the role fiberoptic bronchoscopy in the evaluation of hemoptysis

Authors

  • Ashwin Songara Department of Respiratory Medicine, SAMC and PGI, Indore, Madhya Pradesh
  • Rohit Mukherjee Department of Respiratory Medicine, SAMC and PGI, Indore, Madhya Pradesh
  • Swapnil Shikha Department of Medicine, RML Hospital, Delhi
  • Awadesh P. S. Solanki Department of Psychiatry, IPGMER, Kolkata
  • Tanay Joshi Department of Respiratory Medicine, SAMC and PGI, Indore, Madhya Pradesh
  • Deepika Patel Department of Respiratory Medicine, SAMC and PGI, Indore, Madhya Pradesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20161852

Keywords:

Fiberoptic bronchoscopy (FOB), Hemoptysis, Bronchogenic carcinoma

Abstract

Background: To prospectively evaluate the efficiency of the fiberoptic bronchoscopy (FOB) examination in the evaluation of patients with hemoptysis.

Methods: We prospectively reviewed 50 patients who underwent FOB for hemoptysis. There were 39 male and 11 female. The mean age was 46 years with a range from 21 to 83 years. The patients were divided between two groups on the basis of their chest roentograms (46% with normal and 54% with abnormal findings).

Results: Hemoptysis  in normal  and abnormal chest roentograms was  respectively attributed  to bronchiectasis in         5 (21.7%) and 3 (11.1%) cases, bronchogenic carcinoma in 2 (8.6%)  and 9 (33.3%) cases, bronchitis in 2 (8.6%) and 3 (11.1%) cases, tuberculosis in 2 (8.6%)  and 5 (18.5%) cases, cryptogenic causes in 8 (34.7%)  and 4 (14.8%) cases and pseudohemoptysis  in 2 (8.6%) cases (bleeding from upper respiratory tract).  

Conclusions: Fob plays a pivotal role in the evaluation of hemoptysis. It was found that left upper lobe followed by right upper lobe was the site most consistent with the findings, with bronchogenic carcinoma being the most common non- infectious cause. Infectious etiology was the most common pathology behind hemoptysis and bronchiectasis was the most important risk factor.

References

Lordan JL, Gascoigne A, Corris PA. The pulmonary physician in critical care Illustrative case 7: Assessment and management of massive haemoptysis. Thorax. 2003;58:814-9.

Castaner E, Alguersuari A, Gallardo X. When to suspect pulmonary vasculitis: radiologic and clinical clues. Radiographics. 2010;30(1):33-53.

3. Delage A, Tillie LI, Cavestri B, Wallaert B, Marquette CH. Cryptogenic hemoptysis in chronic obstructive pulmonary disease: characteristics and outcome. Respiration. 2010;80(5):387-92.

Menchini L, Remy JM, Faivre JB. Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients. Eur Respir J. 2009;34(5):1031-9.

Poe RH, Israel RH, Marin MG. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Chest. 1988;93(1):70-5.

Revel MP, Fournier LS, Hennebicque AS. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002;179(5):1217-24.

Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and non-bronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics. 2002;22:1395-409.

Jean BE. Clinical assessment and management of massive hemoptysis. Crit Care Med. 2000;28:1642-7.

Chun JY, Morgan R, Belli AM. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Intervent Radiol. 2010;33:240-50.

Andersen PE. Imaging and interventional radiological treatment of hemoptysis. Acta Radiol. 2006;47:780-92.

Standards atscorod. Diagnostic standards and classification of tuberculosis in adults and children. Atlanta: US Department of Health and Human Services, Public Health Service;2000.

Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. 9th edition. Washington DC: American Society of Microbiology; 2007:1114-45.

Hernandez BL, Sanchez HIM, Villena GV, Miguel PE, Nunez DM, Alfaro AJ. Safety of the transbronchial biopsy in outpatients. Chest. 1991;99:562-5.

Kozak EA, Brath LK. Do ‘screening’ coagulation tests predict bleeding in patients undergoing fibreoptic bronchoscopy with biopsy? Chest. 1994;106:703-5.

Kitchens CS. Preoperative PTs, PTTs, cost effectiveness and health care reform. Radical changes that make good sense. Chest. 1994;106:661-2.

Khan MA, Whitcomb ME, Snider GL. Flexible fiberoptic bronchoscopy. Am J Med. 1976;61:151-5.

Abal AT, Nair PC, Cherian J. Haemoptysis: aetiology, evaluation and outcome:a prospective study in a third-world country. Respir Med. 2001;95:548-52.

Fidan A, Ozdogan S, Oruc O. Hemoptysis: a retrospective analysis of 108 cases. Respir Med. 2002;96:677-80.

Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997;112:440-4.

Neil KM, Lazarus AB. Haemoptysis - indications for bronchoscopy. Arch Intern Med. 1991;151:171-4.

Adelman M, Haponik EK, Blecker EF, Britt EJ. Cryptogenic haemoptysis: clinical features, bronchoscopic findings and natural history in 67 patients. Ann Intern Med. 1985;102:829-34.

Lederle FA, Nichol KL, Parenti CM. Bronchoscopy to evaluate hemoptysis in older men with nonsuspicious chest roentgenograms. Chest. 1989;95(5):1043-7.

Gordon L, Snider, Branko P. The relationship between pulmonary tuberculosis and bronchogenic carcinoma. Am Rev Respiratory Dis. 1969;99(2);229-236.

Khan MA, Whitcomb ME, Snider GL. Flexible fiberoptic bronchoscopy. American Journal of Medicine.1976;61:151-5.

Standards atscorod. Diagnostic standards and classification of tuberculosis in adults and children. Atlanta: US Department of Health and Human Services, Public Health Service;2000.

Zavala DC. Diagnostic fiberoptic bronchoscopy. Chest. 1975;68:12-9.

Suri JC, Goel A, Singla R. Cryptogenic haemoptysis: role of fiberoptic bronchoscopy. Ind J Chest Dis Allied Sci. 1990;32:149-52.

Heaton RW. Should patient with haemoptysis and normal chest x-ray be bronchoscope? Postgrad Med J. 1987;63:947-9.

Sharma SK, Dey AB, Pande JN, Verma K. Fiberoptic bronchoscopy in patients with haemoptysis and normal chest roentgenograms. Ind J Chest Dis Allied Sci. 1991;33:15-8.

Bruzzi JF, Remy JM, Delhaye D, Teisseire A, Khalil C, Remy J. Multi-detector row CT of hemoptysis. Radiographics. 2006;26:3-22.

Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest. 2001;120(5):1592-4.

Mcguinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective highresolution CT/bronchoscopic correlation. Chest. 1994;105(4):1155-62.

Heimer D, Bar ZJ, Scharf SM. Fiberoptic bronchoscopy in patient with haemoptysis and non-localizing chest roentgenogram. Arch Int Med. 1985;145:1427-8.

Jackson CV, Savage PJ, Quinn DL. Role of fiberoptic bronchoscopy in patients with haemoptysis and a normal chest roentgenogram. Chest. 1985;87:142-4.

Haro EM. Utility of history, physical examination and radiography in the localization of bleeding in patients with hemoptysis. An Med Interna. 2002;19:289.

Downloads

Published

2017-01-03

How to Cite

Songara, A., Mukherjee, R., Shikha, S., Solanki, A. P. S., Joshi, T., & Patel, D. (2017). To assess the role fiberoptic bronchoscopy in the evaluation of hemoptysis. International Journal of Research in Medical Sciences, 4(7), 2576–2582. https://doi.org/10.18203/2320-6012.ijrms20161852

Issue

Section

Original Research Articles